61
Participants
Start Date
February 29, 2008
Primary Completion Date
March 31, 2010
Study Completion Date
March 31, 2010
S-1
oral administration
5-Fluorouracil
intravenous bolus
Sanofi-Aventis Administrative Office, Bridgewater
Sanofi-Aventis Administrative Office, Vienna
Sanofi-Aventis Administrative Office, São Paulo
Sanofi-Aventis Administrative Office, Laval
Sanofi-Aventis Administrative Office, San José
Sanofi-Aventis Administrative Office, Hørsholm
Sanofi-Aventis Administrative Office, Paris
Sanofi-Aventis Administrative Office, Athens
Sanofi-Aventis Administrative Office, Mixco
Sanofi-Aventis Administrative Office, Budapest
Sanofi-Aventis Administrative Office, Netanya
Sanofi-Aventis Administrative Office, Ocean Business Plaza
Sanofi-Aventis Administrative Office, Lima
Sanofi-Aventis Administrative Office, Bucharest
Sanofi-Aventis Administrative Office, Midrand
Sanofi-Aventis Administrative Office, Bromma
Sanofi-Aventis Administrative Office, Mégrine
Lead Sponsor
Taiho Pharmaceutical Co., Ltd.
INDUSTRY
Sanofi
INDUSTRY